CXCL5 and hepatocellular carcinoma: In patient specimens, increased TANs were associated with increased CXCL5 expression and miR-301b-3p levels, decreased LSAMP and CYLD expressions, and nuclear p65 accumulation, collectively contributing to immunosuppression and HCC patient prognosis (45).